Bard Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Bard Financial Services's GILD Position: Q3 2025 in Review
Bard Financial Services reduced its Gilead Sciences (GILD) stake by 0.36% in Q3 2025, selling an estimated $11.4K and leaving 27,725 shares worth $3.08M. The position accounts for 0.34% of the portfolio, ranked #72.
Bard Financial Services first reported a position in GILD in Q4 2020 and has held it in 20 quarters since. The position peaked at $3.23M in Q1 2025. 2,032 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Bard Financial Services held 27,725 shares of Gilead Sciences worth $3.08M as of Q3 2025.
- Bard Financial Services sold 100 Gilead Sciences shares in Q3 2025, an estimated $11.4K.
- Gilead Sciences made up 0.34% of Bard Financial Services's portfolio in Q3 2025, its #72 holding.
- Bard Financial Services first reported a position in Gilead Sciences in Q4 2020 and has held it in 20 quarters since.
- Bard Financial Services's Gilead Sciences position peaked at $3.23M in Q1 2025.
- 2,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Bard Financial Services's 13F filing for Q3 2025, filed 17 Oct 2025.